Rachel E. Clough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rachel E. Clough has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
R.E. Bell
Department of Vascular Surgery, NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, King's Health Partners, London, UK
4 shared publications- Bijan Modarai
Academic Department of Vascular Surgery, South Bank Section, School of Cardiovascular and Metabolic Medicine & Sciences, BHF Centre of Excellence, Centre for Academic Surgery, King's College London and King's Health Partners, London, UK
3 shared publications H.A. Zayed
Department of Vascular Surgery, NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, King's Health Partners, London, UK
3 shared publicationsP.R. Taylor
Department of Vascular Surgery, NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, King's Health Partners, London, UK
3 shared publicationsPeter R. Taylor
Department of Vascular Surgery, NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, King's Health Partners, London, UK
3 shared publications- Tobias Schaeffter
Physikalisch‐Technische Bundesanstalt Berlin Germany
3 shared publications
Latest Publications
- Open Access
- 25 March 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-14
The ARIA trial protocol: a randomised controlled trial to assess the clinical, technical, and cost-effectiveness of a cloud-based, ARtificially Intelligent image fusion system in comparison to standard treatment to guide endovascular Aortic aneurysm repair
Background: Endovascular repair of aortic aneurysmal disease is established due to perceived advantages in patient survival, reduced postoperative complications, and shorter hospital lengths of stay. High spatial and contrast resolution 3D CT angiography images are used to plan the procedures and inform device selection and manufacture, but in standard care, the surgery is performed using image-guidance from 2D X-ray fluoroscopy with injection of nephrotoxic contrast material to visualise the blood vessels. This study aims to assess the benefit to patients, practitioners, and the health service of a novel image fusion medical device (Cydar EV), which allows this high-resolution 3D information to be available to operators at the time of surgery. Methods: The trial is a multi-centre, open label, two-armed randomised controlled clinical trial of 340 patient, randomised 1:1 to either standard treatment in endovascular aneurysm repair or treatment using Cydar EV, a CE-marked medical device comprising of cloud computing, augmented intelligence, and computer vision. The primary outcome is procedural time, with secondary outcomes of procedural efficiency, technical effectiveness, patient outcomes, and cost-effectiveness. Patients with a clinical diagnosis of AAA or TAAA suitable for endovascular repair and able to provide written informed consent will be invited to participate. Discussion: This trial is the first randomised controlled trial evaluating advanced image fusion technology in endovascular aortic surgery and is well placed to evaluate the effect of this technology on patient outcomes and cost to the NHS. Trial registration: ISRCTN13832085. Dec. 3, 2021
- 25 March 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-14
Open AccessThe ARIA trial protocol: a randomised controlled trial to assess the clinical, technical, and cost-effectiveness of a cloud-based, ARtificially Intelligent image fusion system in comparison to standard treatment to guide endovascular Aortic aneurysm repair
Background: Endovascular repair of aortic aneurysmal disease is established due to perceived advantages in patient survival, reduced postoperative complications, and shorter hospital lengths of stay. High spatial and contrast resolution 3D CT angiography images are used to plan the procedures and inform device selection and manufacture, but in standard care, the surgery is performed using image-guidance from 2D X-ray fluoroscopy with injection of nephrotoxic contrast material to visualise the blood vessels. This study aims to assess the benefit to patients, practitioners, and the health service of a novel image fusion medical device (Cydar EV), which allows this high-resolution 3D information to be available to operators at the time of surgery. Methods: The trial is a multi-centre, open label, two-armed randomised controlled clinical trial of 340 patient, randomised 1:1 to either standard treatment in endovascular aneurysm repair or treatment using Cydar EV, a CE-marked medical device comprising of cloud computing, augmented intelligence, and computer vision. The primary outcome is procedural time, with secondary outcomes of procedural efficiency, technical effectiveness, patient outcomes, and cost-effectiveness. Patients with a clinical diagnosis of AAA or TAAA suitable for endovascular repair and able to provide written informed consent will be invited to participate. Discussion: This trial is the first randomised controlled trial evaluating advanced image fusion technology in endovascular aortic surgery and is well placed to evaluate the effect of this technology on patient outcomes and cost to the NHS. Trial registration: ISRCTN13832085. Dec. 3, 2021
- Open Access
Management of Uncomplicated Type B Aortic Dissection
Acute aortic dissection has an incidence of approximately half that of symptomatic abdominal and thoracic aneurysm of the aorta and more than twice the mortality of population-based controls. While urgent undelayed open surgery is the strategy of choice in proximal dissection, medical management has been the mainstay of treatment for uncomplicated distal or type B aortic dissection, but endovascular intervention is now considered a potential treatment option for all type B dissection due to its success in complicated cases. Endovascular repair can be technically demanding in aortic dissection, and timing of the repair can have a significant influence on anatomical and clinical outcome. Observational reports of feasibility and reasonable safety are flanked by only two randomised trials; the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) trial demonstrated improved remodelling in acute dissection and the INvestigation of STEnt grafts in patients with type B Aortic Dissections (INSTEAD) trial showed better long-term survival in patients treated endovascularly in the subacute phase. Meta-analyses and other large clinical studies have demonstrated mixed results. Due to some risks associated endovascular repair and the requirement of specialist aortic care (which is not always available), a pragmatic approach for current management could involve high intensity serial imaging in the acute phase of a type B aortic dissection, thereby identifying complicated cases for early intervention and selection of patients at high risk of disease progression for deferred endovascular management in the subacute phase within 90 days.
Open AccessManagement of Uncomplicated Type B Aortic Dissection
Acute aortic dissection has an incidence of approximately half that of symptomatic abdominal and thoracic aneurysm of the aorta and more than twice the mortality of population-based controls. While urgent undelayed open surgery is the strategy of choice in proximal dissection, medical management has been the mainstay of treatment for uncomplicated distal or type B aortic dissection, but endovascular intervention is now considered a potential treatment option for all type B dissection due to its success in complicated cases. Endovascular repair can be technically demanding in aortic dissection, and timing of the repair can have a significant influence on anatomical and clinical outcome. Observational reports of feasibility and reasonable safety are flanked by only two randomised trials; the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) trial demonstrated improved remodelling in acute dissection and the INvestigation of STEnt grafts in patients with type B Aortic Dissections (INSTEAD) trial showed better long-term survival in patients treated endovascularly in the subacute phase. Meta-analyses and other large clinical studies have demonstrated mixed results. Due to some risks associated endovascular repair and the requirement of specialist aortic care (which is not always available), a pragmatic approach for current management could involve high intensity serial imaging in the acute phase of a type B aortic dissection, thereby identifying complicated cases for early intervention and selection of patients at high risk of disease progression for deferred endovascular management in the subacute phase within 90 days.
- 1 February 2017
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 58 (2) , 270-277
Evidence for and risks of endovascular treatment of asymptomatic acute type B aortic dissection
Acute aortic dissection is a challenging disease to manage. Type B aortic dissection has traditionally been divided temporally into acute and chronic cases but more recently this classification has been modified to include a sub-acute phase. Computed tomography is the imaging technique used most frequently in diagnosis and management. Active management of blood pressure is essential and should include beta-blockade unless contraindicated. In-hospital outcomes are generally acceptable in patients with medically managed acute uncomplicated type B aortic dissection, with up to 90% of patients surviving to hospital discharge but by 5 years up to 50% of patients are dead with a significant proportion dying from aortic rupture. The aim of endovascular repair is to treat the complications of the dissection, induce aortic remodeling and false lumen thrombosis and it has been shown to result in good long-term outcomes. Stent graft placement however is associated with an incidence of death, stroke, paraplegia and retrograde type A dissection. Some experts now advocate high intensity imaging in the first 14 days to detect development of complications early in the disease course, with planned elective treatment in the subacute phase.
- 1 February 2017
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 58 (2) , 270-277
Evidence for and risks of endovascular treatment of asymptomatic acute type B aortic dissection
Acute aortic dissection is a challenging disease to manage. Type B aortic dissection has traditionally been divided temporally into acute and chronic cases but more recently this classification has been modified to include a sub-acute phase. Computed tomography is the imaging technique used most frequently in diagnosis and management. Active management of blood pressure is essential and should include beta-blockade unless contraindicated. In-hospital outcomes are generally acceptable in patients with medically managed acute uncomplicated type B aortic dissection, with up to 90% of patients surviving to hospital discharge but by 5 years up to 50% of patients are dead with a significant proportion dying from aortic rupture. The aim of endovascular repair is to treat the complications of the dissection, induce aortic remodeling and false lumen thrombosis and it has been shown to result in good long-term outcomes. Stent graft placement however is associated with an incidence of death, stroke, paraplegia and retrograde type A dissection. Some experts now advocate high intensity imaging in the first 14 days to detect development of complications early in the disease course, with planned elective treatment in the subacute phase.
- 1 December 2016
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 52 (6) , 746
Commentary on “Computational Study of Anatomical Risk Factors in Idealized Models of Type B Aortic Dissection”
- 1 December 2016
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 52 (6) , 746
Commentary on “Computational Study of Anatomical Risk Factors in Idealized Models of Type B Aortic Dissection”
- 1 June 2016
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 51 (6) , 790
Commentary on ‘Morphological Differences in the Aorto-iliac Segment in AAA Patients of Caucasian and Asian Origin’
- 1 June 2016
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 51 (6) , 790
Commentary on ‘Morphological Differences in the Aorto-iliac Segment in AAA Patients of Caucasian and Asian Origin’
- Open Access
- 5 October 2015
- Published by Springer Nature in Gefässchirurgie
- Vol. 20 (6) , 420-427
Modern diagnostics for type B aortic dissection
Undifferentiated chest pain is one of the most common complaints in the acute care setting. Type B aortic dissection is an important cause of chest pain and a complex clinical entity, which carries significant morbidity and mortality and requires accurate clinical and radiological evaluation.
- 5 October 2015
- Published by Springer Nature in Gefässchirurgie
- Vol. 20 (6) , 420-427
Open AccessModern diagnostics for type B aortic dissection
Undifferentiated chest pain is one of the most common complaints in the acute care setting. Type B aortic dissection is an important cause of chest pain and a complex clinical entity, which carries significant morbidity and mortality and requires accurate clinical and radiological evaluation.
- 1 October 2015
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 50 (4) , 442
Renal Outcome After Open Surgery and Fenestrated Endovascular Aneurysm Repair of Juxta-renal Aneurysms
- 1 October 2015
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 50 (4) , 442
Renal Outcome After Open Surgery and Fenestrated Endovascular Aneurysm Repair of Juxta-renal Aneurysms
- 1 September 2014
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 48 (3) , 268-275
Pathology Specific Early Outcome after Thoracic Endovascular Aortic Repair
- 1 September 2014
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 48 (3) , 268-275
Pathology Specific Early Outcome after Thoracic Endovascular Aortic Repair
- 18 June 2014
- Vol. 55 (4) , 529-41
Optimising pre- and postoperative imaging for thoracic aortic pathology.
Thoracic aortic pathology carries significant morbidity and mortality, which requires prompt and accurate clinical and radiological evaluation. Advances in imaging technologies have improved our knowledge of the mechanisms of growth and rupture and our understanding of endovascular repair. Computed tomography has become a crucial component in this process, replacing catheter-based angiography as the most commonly used pre- and postoperative imaging modality for the thoracic aorta. Functional imaging methods such as magnetic resonance and echocardiography are evolving and are able to provide the clinically relevant anatomic, haemodynamic and biomechanical information that is necessary for accurate diagnosis, risk stratification and selection of the appropriate treatment for an individual patient. The availability of advanced image acquisition expertise and equipment is spreading to a growing number of institutions worldwide and will greatly enhance existing imaging strategies for patients with thoracic aortic pathology.
- 18 June 2014
- Vol. 55 (4) , 529-41
Optimising pre- and postoperative imaging for thoracic aortic pathology.
Thoracic aortic pathology carries significant morbidity and mortality, which requires prompt and accurate clinical and radiological evaluation. Advances in imaging technologies have improved our knowledge of the mechanisms of growth and rupture and our understanding of endovascular repair. Computed tomography has become a crucial component in this process, replacing catheter-based angiography as the most commonly used pre- and postoperative imaging modality for the thoracic aorta. Functional imaging methods such as magnetic resonance and echocardiography are evolving and are able to provide the clinically relevant anatomic, haemodynamic and biomechanical information that is necessary for accurate diagnosis, risk stratification and selection of the appropriate treatment for an individual patient. The availability of advanced image acquisition expertise and equipment is spreading to a growing number of institutions worldwide and will greatly enhance existing imaging strategies for patients with thoracic aortic pathology.
- Open Access
- 1 May 2014
- Vol. 3 (3) , 314-318-318
Usefulness of new imaging methods for assessment of type B aortic dissection
Usefulness of new imaging methods for assessment of type B aortic dissection
- 1 May 2014
- Vol. 3 (3) , 314-318-318
Open AccessUsefulness of new imaging methods for assessment of type B aortic dissection
Usefulness of new imaging methods for assessment of type B aortic dissection